Clinical Trial Update: Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 study evaluating immune and microRNA responses to recombinant interferon beta in healthy volunteers and relapsing-remitting multiple sclerosis patients.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Interferon-beta (interferon beta)

Snippet

Sponsor: PD Dr. Marcus Müller | Conditions: Relapsing-remitting Multiple Sclerosis | Phase 1 | Status: UNKNOWN